Jan Konvalinka
- Molecular Biology top 5%
- Virology top 0.5%
- Infectious Diseases top 1%
- Radiology, Nuclear Medicine and Imaging top 1%
- Oncology top 5%
- Co-authors
- Hans‐Georg KräusslichCyril BařinkaJ.J.F. SchöltenPavel ŠáchaPavel MajerPavlína ŘezáčováMilan KožíšekJ. Brynda
- Topics
- HIV/AIDS drug development and treatment (61 papers)HIV Research and Treatment (57 papers)Peptidase Inhibition and Analysis (28 papers)
- Journals
- Proceedings of the National Academy of SciencesNucleic Acids ResearchJournal of Biological Chemistry
- Partner nations
- CzechiaUnited StatesGermany
In The Last Decade
Jan Konvalinka
164 papers receiving 5.6k citations
Peers
Comparison fields: 5 of 139
- Molecular Biology 2.3k
- Virology 1.5k
- Infectious Diseases 1.5k
- Radiology, Nuclear Medicine and Imaging 1.0k
- Oncology 726
Countries citing papers authored by Jan Konvalinka
This map shows the geographic impact of Jan Konvalinka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Konvalinka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Konvalinka more than expected).
Fields of papers citing papers by Jan Konvalinka
This network shows the impact of papers produced by Jan Konvalinka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Konvalinka. The network helps show where Jan Konvalinka may publish in the future.
Co-authorship network of co-authors of Jan Konvalinka
This figure shows the co-authorship network connecting the top 25 collaborators of Jan Konvalinka. A scholar is included among the top collaborators of Jan Konvalinka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Konvalinka. Jan Konvalinka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 11 | |
| 7 | 33 | |
| 8 | 4 | |
| 9 | 5 | |
| 10 | 13 | |
| 11 | 23 | |
| 12 | 22 | |
| 13 | 20 | |
| 14 | 13 | |
| 15 | 72 | |
| 16 | 17 | |
| 17 | Co nového víme o PSMA (prostatický specifický membránový antigen): z pohledu urologa | 1 |
| 18 | 269 | |
| 19 | 24 | |
| 20 | 36 |
About Jan Konvalinka
Jan Konvalinka is a scholar working on Virology, Infectious Diseases and Biochemistry, having authored 171 papers that have together received 5.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (61 papers), HIV Research and Treatment (57 papers) and Peptidase Inhibition and Analysis (28 papers). The work is most often cited by research in Virology (1.5k citations), Infectious Diseases (1.5k citations) and Biochemistry (345 citations). Jan Konvalinka has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Hans‐Georg Kräusslich, Cyril Bařinka, J.J.F. Schölten, Pavel Šácha, Pavel Majer, Pavlína Řezáčová, Milan Kožíšek, J. Brynda, Barbara S. Slusher and Jana Pokorná. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.